Pharma 4.0: Revealing Drivers of the Digital Transformation in the Pharma Sector

2Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The primary goal of this paper was to uncover the drivers of digital transformation (DT) in the pharmaceutical industry. The Covid-19 pandemic and tightening regulatory standards in the global pharma industry necessitated pharma executives need to understand the most critical drivers of digitalizing the sector and charting a new path that improves production processes and streamlines these companies’ overall supply chain. This research aims to identify the drivers for DT in the pharmaceutical industry. The Web of Science Core Collection and Scopus gathered relevant data for the research study. The research employs objective analysis to ensure that more reliable conclusions were drawn following the study. The study also proposed that external and internal factors, such as supply chain difficulties and data silos, impact DT adoption in the pharmaceutical sector.

Cite

CITATION STYLE

APA

Tetteh, M. G., Jagtap, S., & Salonitis, K. (2023). Pharma 4.0: Revealing Drivers of the Digital Transformation in the Pharma Sector. In Lecture Notes in Mechanical Engineering (pp. 528–535). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/978-3-031-28839-5_59

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free